{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:38:17Z","timestamp":1780393097067,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Yunnan Provincial Education Department Scientific Research Fund Project","award":["2024Y224"],"award-info":[{"award-number":["2024Y224"]}]},{"name":"the Yunnan Provincial Education Department Scientific Research Fund Project","award":["2025J0162"],"award-info":[{"award-number":["2025J0162"]}]},{"name":"the Graduate Innovation Fund of Kunming Medical University","award":["2025B009"],"award-info":[{"award-number":["2025B009"]}]},{"name":"the Foundation Projects of Applied Basic Research Joint Science and Technology Ministry of Yunnan Province with Kunming Medical University","award":["202401AY070001-356"],"award-info":[{"award-number":["202401AY070001-356"]}]},{"name":"the Science and Technology Program of Yunnan Province","award":["202401AT070068"],"award-info":[{"award-number":["202401AT070068"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260087"],"award-info":[{"award-number":["82260087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Program Innovative Research Team in Science and Technology (\u201cXingdian Talents\u201d Support Project) of Yunnan Province","award":["202405AS350014"],"award-info":[{"award-number":["202405AS350014"]}]},{"name":"the Yunnan Health Training Project of High Level Talents","award":["L-2019025"],"award-info":[{"award-number":["L-2019025"]}]},{"name":"the Famous Doctor Special Project of the Yunnan Health Training Project of High-Level Talents","award":["RLMY20190006"],"award-info":[{"award-number":["RLMY20190006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extracorporeal cardiac shock wave (ECSW) therapy enhances the function of endothelial colony-forming cells (ECFCs), but whether it can serve as a preconditioning strategy to enhance myocardial infarction (MI) therapy remains unclear. This study investigated the efficacy and mechanism of intravenously delivered ECSW-preconditioned ECFCs (SW-ECFCs) in a rat MI model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      ECFCs were isolated from the bone marrow of ApoE\n                      <jats:sup>-\/-<\/jats:sup>\n                      rats and fully characterized. RNA sequencing of control ECFCs versus SW-ECFCs revealed significant enrichment of the PI3K\/AKT pathway. We therefore performed a series of in vitro functional assays on these cells, including Transwell migration, Matrigel tube formation, CCK-8 proliferation, flow cytometric apoptosis analysis, and VEGF-A ELISA. . The role of the PI3K\/AKT pathway was interrogated using the inhibitor LY294002. Subsequently, an acute MI model was established in ApoE\n                      <jats:sup>-\/-<\/jats:sup>\n                      rats via left anterior descending coronary artery ligation. Rats were randomized into four groups: MI\u2009+\u2009PBS, MI\u2009+\u2009ECFCs, MI\u2009+\u2009SW-ECFCs, and MI\u2009+\u2009LY294002-pretreated SW-ECFCs (LY-SW-ECFCs), with sham-operated rats as controls. Comprehensive evaluations included echocardiography, serum injury biomarkers, TTC, and histopathological (H&amp;E, Masson) staining, immunohistochemical detection of cardiomyocyte apoptosis and p-eNOS, immunofluorescence assessment of ECFC homing and vascular markers (CD31, \u03b1-SMA, VEGF-A), tissue\/plasma nitric oxide measurement, and Western blot analysis of PI3K\/AKT signaling proteins.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transcriptomic analysis revealed significant enrichment of the PI3K\/AKT pathway in SW-ECFCs. Functionally, ECSW enhanced ECFCs migration, tube formation, proliferation, and VEGF-A secretion, while reducing apoptosis; these effects were largely abolished by PI3K inhibition. In vivo, serum levels of CK, CK-MB, and LDH were significantly elevated in all MI groups compared to the Sham group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), indicating comparable initial injury. However, no significant differences were observed among treatment groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). SW-ECFCs transplantation significantly improved cardiac function, reduced infarct size, fibrosis, and apoptosis, and enhanced angiogenesis (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). These benefits were associated with increased levels of p-AKT, p-eNOS, and BCL-2 protein as well as nitric oxide content, while suppressing the expression of cleaved caspase-3 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Crucially, all these therapeutic benefits were largely abolished by PI3K inhibition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, this study demonstrates that preconditioning ECFCs with ECSW significantly enhances their therapeutic efficacy for myocardial infarction, improving both cardiac function and structural repair. These benefits are mediated primarily through activation of the PI3K\/AKT signaling pathway, which augments cell homing, paracrine activity, and survival, thereby providing a novel and promising strategy for cardiac regeneration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-026-04913-w","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:15:55Z","timestamp":1769940955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extracorporeal cardiac shock wave stimulation enhances the therapeutic efficacy of intravenously delivered endothelial colony-forming cells via PI3K\/AKT signaling in a rat myocardial infarction model"],"prefix":"10.1186","volume":"17","author":[{"given":"Mingqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunke","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Lun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"issue":"8","key":"4913_CR1","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS. Heart disease and stroke Statistics-2023 update: A report from the American heart association. Circulation. 2023;147(8):e93\u2013621. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.","journal-title":"Circulation"},{"issue":"5","key":"4913_CR2","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1097\/CCM.0000000000003051","volume":"46","author":"PH Sung","year":"2018","unstructured":"Sung PH, Lee FY, Tong MS, Chiang JY, Pei SN, Ma MC, Li YC, Chen YL, Wu CJ, Sheu JJ, Lee MS, Yip HK. The Five-Year clinical and angiographic Follow-Up outcomes of intracoronary transfusion of Circulation-Derived CD34\u2009+\u2009Cells for patients with End-Stage diffuse coronary artery disease unsuitable for coronary Intervention-Phase I clinical trial. Crit Care Med. 2018;46(5):e411\u20138.","journal-title":"Crit Care Med"},{"issue":"7","key":"4913_CR3","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.2174\/1381612823666161123145148","volume":"23","author":"D Kocyigit","year":"2017","unstructured":"Kocyigit D, Gurses KM, Yalcin MU, Tokgozoglu L. Traditional and alternative therapies for refractory angina. Curr Pharm Des. 2017;23(7):1098\u2013111.","journal-title":"Curr Pharm Des"},{"issue":"9","key":"4913_CR4","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3727\/096368916X691484","volume":"25","author":"TD Henry","year":"2016","unstructured":"Henry TD, Schaer GL, Traverse JH, Povsic TJ, Davidson C, Lee JS, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Patel AN, Riedel N, Junge C, Hunt A, Kereiakes DJ, White C, Harrington RA, Schatz RA, Losordo DW. ACT. Autologous CD34\u2009+\u2009Cell therapy for refractory angina: 2-Year outcomes from the ACT34-CMI study. Cell Transpl. 2016;25(9):1701\u201311.","journal-title":"Cell Transpl"},{"key":"4913_CR5","doi-asserted-by":"publisher","first-page":"9847015","DOI":"10.1155\/2018\/9847015","volume":"2018","author":"H Chopra","year":"2018","unstructured":"Chopra H, Hung MK, Kwong DL, Zhang CF, Pow EHN. Insights into endothelial progenitor cells: Origin, Classification, Potentials, and prospects. Stem Cells Int. 2018;2018:9847015.","journal-title":"Stem Cells Int"},{"issue":"23","key":"4913_CR6","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1093\/eurheartj\/ehx764","volume":"39","author":"TD Henry","year":"2018","unstructured":"Henry TD, Losordo DW, Traverse JH, Schatz RA, Jolicoeur EM, Schaer GL, Clare R, Chiswell K, White CJ, Fortuin FD, Kereiakes DJ, Zeiher AM, Sherman W, Hunt AS, Povsic TJ. Autologous CD34\u2009+\u2009cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. Eur Heart J. 2018;39(23):2208\u201316.","journal-title":"Eur Heart J"},{"issue":"1","key":"4913_CR7","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/hh1301.093953","volume":"89","author":"M Vasa","year":"2001","unstructured":"Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of Circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1\u20137.","journal-title":"Circ Res"},{"key":"4913_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.atherosclerosis.2017.03.023","volume":"260","author":"E Nollet","year":"2017","unstructured":"Nollet E, Hoymans VY, Rodrigus IR, De Bock D, Dom M, Van Hoof VOM, Vrints CJ, Van Craenenbroeck EM. Accelerated cellular senescence as an underlying mechanism for functionally impaired bone marrow-derived progenitor cells in ischemic heart disease. Atherosclerosis. 2017;260:138\u201346.","journal-title":"Atherosclerosis"},{"issue":"1","key":"4913_CR9","doi-asserted-by":"publisher","first-page":"e000342","DOI":"10.1136\/openhrt-2015-000342","volume":"3","author":"J Watt","year":"2016","unstructured":"Watt J, Kennedy S, Ahmed N, Hayhurst J, McClure JD, Berry C, Wadsworth RM, Oldroyd KG. The relationship between oxidised LDL, endothelial progenitor cells and coronary endothelial function in patients with CHD. Open Heart. 2016;3(1):e000342.","journal-title":"Open Heart"},{"issue":"9 Suppl","key":"4913_CR10","first-page":"I117","volume":"112","author":"C Kupatt","year":"2005","unstructured":"Kupatt C, Hinkel R, Lamparter M, von Br\u00fchl ML, Pohl T, Horstkotte J, Beck H, M\u00fcller S, Delker S, Gildehaus FJ, B\u00fcning H, Hatzopoulos AK, Boekstegers P. Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase\/AKT kinase. Circulation. 2005;112(9 Suppl):I117\u2013122.","journal-title":"Circulation"},{"issue":"5","key":"4913_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1535-6108(04)00116-3","volume":"5","author":"J Wei","year":"2004","unstructured":"Wei J, Blum S, Unger M, Jarmy G, Lamparter M, Geishauser A, Vlastos GA, Chan G, Fischer KD, Rattat D, Debatin KM, Hatzopoulos AK, Beltinger C. Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell. 2004;5(5):477\u201388.","journal-title":"Cancer Cell"},{"key":"4913_CR12","doi-asserted-by":"publisher","first-page":"9682757","DOI":"10.1155\/2016\/9682757","volume":"2016","author":"L Li","year":"2016","unstructured":"Li L, Chen X, Wang WE, Zeng C. How to improve the survival of transplanted mesenchymal stem cell in ischemic heart? Stem Cells Int. 2016;2016:9682757.","journal-title":"Stem Cells Int"},{"issue":"14","key":"4913_CR13","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.108.777102","volume":"118","author":"V Sch\u00e4chinger","year":"2008","unstructured":"Sch\u00e4chinger V, Aicher A, D\u00f6bert N, R\u00f6ver R, Diener J, Fichtlscherer S, Assmus B, Seeger FH, Menzel C, Brenner W, Dimmeler S, Zeiher AM. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation. 2008;118(14):1425\u201332.","journal-title":"Circulation"},{"issue":"2","key":"4913_CR14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/jcmm.14035","volume":"23","author":"L Zhao","year":"2019","unstructured":"Zhao L, Hu C, Zhang P, Jiang H, Chen J. Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury. J Cell Mol Med. 2019;23(2):720\u201330.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"4913_CR15","first-page":"2404","volume":"29","author":"N Jia","year":"2022","unstructured":"Jia N, Zhang R, Liu B, Liu B, Qi X, Lan M, Liu J, Zeng P, Chen C, Li W, Guo Y, Yao Z, He Q. Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: A randomized, double-blind control study. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2022;29(5):2404\u201319.","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"key":"4913_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.amjcard.2020.12.065","volume":"144","author":"C Martinez-Sanchez","year":"2021","unstructured":"Martinez-Sanchez C, Azar-Manzur F, Gonzalez-Pacheco H, Amezcua-Guerra LM, Masso F, Marquez-Velasco R, Bojalil R, Carvajal-Juarez I, Alexanderson-Rosas E, Hernandez S, Paez-Arenas A, Lopez-Mora E, Venegas-Roman A, Brianza-Padilla M, Gopar-Nieto R, Sandoval J. Effectiveness and safety of extracorporeal shockwave myocardial revascularization in patients with refractory angina pectoris and heart failure. Am J Cardiol. 2021;144:26\u201332.","journal-title":"Am J Cardiol"},{"key":"4913_CR17","doi-asserted-by":"publisher","first-page":"554306","DOI":"10.3389\/fvets.2020.554306","volume":"7","author":"R Salcedo-Jim\u00e9nez","year":"2020","unstructured":"Salcedo-Jim\u00e9nez R, Koenig JB, Lee OJ, Gibson TWG, Madan P, Koch TG. Extracorporeal shock wave therapy enhances the in vitro metabolic activity and differentiation of equine umbilical cord blood mesenchymal stromal cells. Front Vet Sci. 2020;7:554306.","journal-title":"Front Vet Sci"},{"key":"4913_CR18","doi-asserted-by":"publisher","first-page":"747497","DOI":"10.3389\/fcvm.2021.747497","volume":"8","author":"M Wang","year":"2021","unstructured":"Wang M, Yang D, Hu Z, Shi Y, Ma Y, Cao X, Guo T, Cai H, Cai H. Extracorporeal cardiac shock waves therapy improves the function of endothelial progenitor cells after hypoxia injury via activating PI3K\/Akt\/eNOS signal pathway. Front Cardiovasc Med. 2021;8:747497.","journal-title":"Front Cardiovasc Med"},{"issue":"20","key":"4913_CR19","doi-asserted-by":"publisher","first-page":"e010025","DOI":"10.1161\/JAHA.118.010025","volume":"7","author":"C Gollmann-Tepek\u00f6yl\u00fc","year":"2018","unstructured":"Gollmann-Tepek\u00f6yl\u00fc C, Lobenwein D, Theurl M, Primessnig U, Lener D, Kirchmair E, Mathes W, Graber M, P\u00f6lzl L, An A, Koziel K, Pechriggl E, Voelkl J, Paulus P, Schaden W, Grimm M, Kirchmair R, Holfeld J. Shock wave therapy improves cardiac function in a model of chronic ischemic heart failure: evidence for a mechanism involving VEGF signaling and the extracellular matrix. J Am Heart Assoc. 2018;7(20):e010025.","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"4913_CR20","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1001\/jama.2013.3527","volume":"309","author":"B Assmus","year":"2013","unstructured":"Assmus B, Walter DH, Seeger FH, Leistner DM, Steiner J, Ziegler I, Lutz A, Khaled W, Klotsche J, Tonn T, Dimmeler S, Zeiher AM. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. JAMA. 2013;309(15):1622\u201331.","journal-title":"JAMA"},{"issue":"4","key":"4913_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/cvr\/cvab135","volume":"118","author":"R Bolli","year":"2022","unstructured":"Bolli R, Solankhi M, Tang XL, Kahlon A. Cell therapy in patients with heart failure: a comprehensive review and emerging concepts. Cardiovasc Res. 2022;118(4):951\u201376.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"4913_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCRESAHA.118.313251","volume":"123","author":"M Wysoczynski","year":"2018","unstructured":"Wysoczynski M, Khan A, Bolli R. New paradigms in cell therapy: repeated Dosing, intravenous Delivery, Immunomodulatory Actions, and new cell types. Circ Res. 2018;123(2):138\u201358.","journal-title":"Circ Res"},{"issue":"6","key":"4913_CR23","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412.","journal-title":"PLoS Biol"},{"key":"4913_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.atherosclerosis.2018.02.015","volume":"271","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Yang Y, Xing R, Cui X, Xiao Y, Xie L, You P, Wang T, Zeng L, Peng W, Li D, Chen H, Liu M. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats. Atherosclerosis. 2018;271:26\u201335.","journal-title":"Atherosclerosis"},{"key":"4913_CR25","doi-asserted-by":"publisher","first-page":"779936","DOI":"10.3389\/fcell.2021.779936","volume":"9","author":"D Yang","year":"2021","unstructured":"Yang D, Wang M, Hu Z, Ma Y, Shi Y, Cao X, Guo T, Cai H, Cai H. Extracorporeal cardiac shock Wave-Induced exosome derived from endothelial Colony-Forming cells carrying miR-140-3p alleviate cardiomyocyte Hypoxia\/Reoxygenation injury via the PTEN\/PI3K\/AKT pathway. Front Cell Dev Biol. 2021;9:779936.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"4913_CR26","first-page":"3895","volume":"12","author":"Y Ma","year":"2020","unstructured":"Ma Y, Hu Z, Yang D, Li L, Wang L, Xiao J, Cao X, Shi Y, Cai H. Extracorporeal cardiac shock waves therapy promotes function of endothelial progenitor cells through PI3K\/AKT and MEK\/ERK signaling pathways. Am J Transl Res. 2020;12(7):3895\u2013905.","journal-title":"Am J Transl Res"},{"issue":"4","key":"4913_CR27","doi-asserted-by":"publisher","first-page":"H455","DOI":"10.1152\/ajpheart.00726.2015","volume":"310","author":"L Hou","year":"2016","unstructured":"Hou L, Kim JJ, Woo YJ, Huang NF. Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease. Am J Physiol Heart Circ Physiol. 2016;310(4):H455\u2013465.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"4913_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/CIRCRESAHA.116.310340","volume":"120","author":"BA Tompkins","year":"2017","unstructured":"Tompkins BA, Natsumeda M, Balkan W, Hare JM. What is the future of Cell-Based therapy for acute myocardial infarction. Circ Res. 2017;120(2):252\u20135.","journal-title":"Circ Res"},{"issue":"1","key":"4913_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s13287-025-04678-8","volume":"16","author":"X Wan","year":"2025","unstructured":"Wan X, Qian C, Liu S, Xu Y, Yuan J, Zhang X, Li X. Stem cell therapy for myocardial infarction and atherosclerosis: mechanisms, challenges, and future directions. Stem Cell Res Ther. 2025;16(1):551.","journal-title":"Stem Cell Res Ther"},{"issue":"5302","key":"4913_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302):964\u20137.","journal-title":"Science"},{"issue":"9","key":"4913_CR31","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1161\/ATVBAHA.107.155960","volume":"28","author":"KK Hirschi","year":"2008","unstructured":"Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008;28(9):1584\u201395.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"4913_CR32","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1161\/01.CIR.0000058702.69484.A0","volume":"107","author":"J Rehman","year":"2003","unstructured":"Rehman J, Li J, Orschell CM, March KL. Peripheral blood endothelial progenitor cells are derived from monocyte\/macrophages and secrete angiogenic growth factors. Circulation. 2003;107(8):1164\u20139.","journal-title":"Circulation"},{"issue":"11","key":"4913_CR33","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1167\/iovs.09-4951","volume":"51","author":"RJ Medina","year":"2010","unstructured":"Medina RJ, O\u2019Neill CL, Humphreys MW, Gardiner TA, Stitt AW. Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Invest Ophthalmol Vis Sci. 2010;51(11):5906\u201313.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"4913_CR34","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1182\/blood-2004-04-1396","volume":"104","author":"DA Ingram","year":"2004","unstructured":"Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104(9):2752\u201360.","journal-title":"Blood"},{"issue":"12","key":"4913_CR35","doi-asserted-by":"publisher","first-page":"a041154","DOI":"10.1101\/cshperspect.a041154","volume":"12","author":"JM Melero-Martin","year":"2022","unstructured":"Melero-Martin JM. Human endothelial Colony-Forming cells. Cold Spring Harb Perspect Med. 2022;12(12):a041154.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"4913_CR36","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13287-024-04015-5","volume":"15","author":"YW Cheng","year":"2024","unstructured":"Cheng YW, Yang LY, Chen YT, Chou SC, Chen KW, Chen YH, Deng CR, Chen IC, Chou WJ, Chang CC, Chen YR, Hwa HL, Wang KC, Kuo MF. Endothelial progenitor cell-derived conditioned medium mitigates chronic cerebral ischemic injury through macrophage migration inhibitory factor-activated AKT pathway. Stem Cell Res Ther. 2024;15(1):428.","journal-title":"Stem Cell Res Ther"},{"issue":"16","key":"4913_CR37","doi-asserted-by":"publisher","first-page":"8074","DOI":"10.1111\/jcmm.16739","volume":"25","author":"V Balducci","year":"2021","unstructured":"Balducci V, Faris P, Balbi C, Costa A, Negri S, Rosti V, Bollini S, Moccia F. The human amniotic fluid stem cell secretome triggers intracellular Ca2\u2009+\u2009oscillations, NF-\u03baB nuclear translocation and tube formation in human endothelial colony-forming cells. J Cell Mol Med. 2021;25(16):8074\u201386.","journal-title":"J Cell Mol Med"},{"issue":"15","key":"4913_CR38","doi-asserted-by":"publisher","first-page":"12298","DOI":"10.3390\/ijms241512298","volume":"24","author":"M Mart\u00edn-B\u00f3rnez","year":"2023","unstructured":"Mart\u00edn-B\u00f3rnez M, Falc\u00f3n D, Morrugares R, Siegfried G, Khatib AM, Rosado JA, Galeano-Otero I, Smani T. New insights into the reparative angiogenesis after myocardial infarction. Int J Mol Sci. 2023;24(15):12298.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"4913_CR39","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1161\/01.CIR.0000148849.51177.97","volume":"110","author":"T Nishida","year":"2004","unstructured":"Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, Matsumoto Y, Kajihara N, Eto M, Matsuda T, Yasui H, Takeshita A, Sunagawa K. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation. 2004;110(19):3055\u201361.","journal-title":"Circulation"},{"issue":"6","key":"4913_CR40","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/cvr\/cvz209","volume":"116","author":"C Gollmann-Tepek\u00f6yl\u00fc","year":"2020","unstructured":"Gollmann-Tepek\u00f6yl\u00fc C, P\u00f6lzl L, Graber M, Hirsch J, N\u00e4gele F, Lobenwein D, Hess MW, Blumer MJ, Kirchmair E, Zipperle J, Hromada C, M\u00fchleder S, Hackl H, Hermann M, Al Khamisi H, F\u00f6rster M, Lichtenauer M, Mittermayr R, Paulus P, Fritsch H, Bonaros N, Kirchmair R, Sluijter JPG, Davidson S, Grimm M, Holfeld J. miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy. Cardiovasc Res. 2020;116(6):1226\u201336.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"4913_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cardiores.2005.04.011","volume":"67","author":"J Dow","year":"2005","unstructured":"Dow J, Simkhovich BZ, Kedes L, Kloner RA. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res. 2005;67(2):301\u20137.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"4913_CR42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ejcts.2006.11.057","volume":"31","author":"X Hu","year":"2007","unstructured":"Hu X, Wang J, Chen J, Luo R, He A, Xie X, Li J. Optimal Temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2007;31(3):438\u201343.","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"key":"4913_CR43","doi-asserted-by":"publisher","first-page":"19155","DOI":"10.1038\/srep19155","volume":"6","author":"D Mu","year":"2016","unstructured":"Mu D, Zhang XL, Xie J, Yuan HH, Wang K, Huang W, Li GN, Lu JR, Mao LJ, Wang L, Cheng L, Mai XL, Yang J, Tian CS, Kang LN, Gu R, Zhu B, Xu B. Intracoronary transplantation of mesenchymal stem cells with overexpressed Integrin-Linked kinase improves cardiac function in Porcine myocardial infarction. Sci Rep. 2016;6:19155.","journal-title":"Sci Rep"},{"issue":"10","key":"4913_CR44","doi-asserted-by":"publisher","first-page":"18544","DOI":"10.1002\/jcp.28492","volume":"234","author":"B Zhang","year":"2019","unstructured":"Zhang B, Jiang H, Chen J, Hu Q, Yang S, Liu X. Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction. J Cell Physiol. 2019;234(10):18544\u201359.","journal-title":"J Cell Physiol"},{"key":"4913_CR45","doi-asserted-by":"publisher","first-page":"963689724125314","DOI":"10.1177\/09636897241253144","volume":"33","author":"JJ Sheu","year":"2024","unstructured":"Sheu JJ, Yeh JN, Sung PH, Chiang JY, Chen YL, Wang YT, Yip HK, Guo J. ITRI biofilm prevented thoracic adhesion in pigs that received myocardial ischemic induction treated by myocardial implantation of EPCs and ECSW treatment. Cell Transpl. 2024;33:9636897241253144.","journal-title":"Cell Transpl"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-04913-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04913-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04913-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:12:48Z","timestamp":1772453568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-04913-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4913"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-04913-w","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve informed consent from clinical patients. Ethical approval for this study (kmmu2021109, Mechanism of extracorporeal cardiac shock wave preventing and treating coronary heart disease by promoting endothelial progenitor Cells function via the PI3K\/Akt\/eNOS pathway). It was obtained from the Animal Ethics Committee of Kunming Medical University on February 26, 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to the publication of this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}